Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Venetoclax + Blinatumomab in R/R BCP-ALL
NCT05182385Phase 2Active, not recruiting
- Sponsor
- Goethe University Frankfurt
- Start
- Dec 2021
- Primary completion
- Apr 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of venetoclax in acute lymphoblastic leukemia (ALL), sponsored by Goethe University Frankfurt. Started Dec 2021; status: active, not recruiting.
02
Drugs
venetoclax
03
Conditions
acute lymphoblastic leukemia (ALL)
Beyond the preview
Go deeper on NCT05182385.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05182385.